Marker Therapeutics, Inc.
MRKR
$1.02
-$0.0801-7.28%
MRKR
Valuation
MRKR
Low
2-Year Historical Range
MRKR
Average
High
Market Cap
11.78M
< 11.78M
> 64.50M
Enterprise Value
-7.41M
-7.41M
> 50.00M
Price/Earnings (TTM)
-1.00
-9.26
0.00
Earnings Per Share Growth (TTM)
0.64%
-78.35%
0.64%
Price/Earnings To Growth (TTM)
--
--
--
Price/Sales (TTM)
1.82
0.72
15.98
Price/Book (Q)
1.32
0.33
5.82
Enterprise Value/Revenue (TTM)
-1.37
-1.37
> 10.00
Enterprise Value/EBITDA (TTM)
3.31
< -10.00
3.31
Enterprise Value/EBIT (TTM)
0.73
-3.37
0.73
Dividends and Shares
MRKR
Low
2-Year Historical Range
MRKR
Average
High
Shares Outstanding
8.92M
8.37M
8.92M
Dividend Per Share (Most Recent)
--
--
--
Dividend Per Share (TTM)
--
--
--
Dividend Yield (TTM)
--
--
--
Payout Ratio (TTM)
--
--
--
Price History
MRKR
Low
2-Year Historical Range
MRKR
Average
High
Beta
1.69
0.68
2.50
1-Month Total Return
-20.29%
< -30.00%
> 20.00%
3-Month Total Return
-64.69%
< -70.00%
> 70.00%
6-Month Total Return
-60.71%
< -70.00%
> 60.00%
Year to Date Total Return
-65.41%
< -70.00%
> 0.00%
1-Year Total Return
-77.46%
< -80.00%
> 70.00%
2-Year Total Return
33.72%
< -60.00%
> 40.00%
3-Year Total Return
-75.88%
-96.29%
-52.82%
5-Year Total Return
-94.15%
-97.99%
-84.27%
Profitability
MRKR
Low
2-Year Historical Range
MRKR
Average
High
Operating Margin (TTM)
-188.93%
-681.04%
-188.93%
Profit Margin (TTM)
-179.71%
< -770.00%
-170.49%
Management Effectiveness
MRKR
Low
2-Year Historical Range
MRKR
Average
High
Return on Assets (TTM)
-41.92%
-41.92%
-27.81%
Return on Equity (TTM)
--
--
--
Income Statement
MRKR
Low
2-Year Historical Range
MRKR
Average
High
Revenue (TTM)
5.40M
3.01M
5.40M
Total Revenue (TTM)
5.40M
3.01M
5.40M
Total Revenue Growth (Q YOY)
647.67%
< 60.00%
647.67%
Revenue Per Share (TTM)
0.60
0.37
1.47
Gross Profit (TTM)
-5.60M
-12.21M
-5.60M
EBITDA (TTM)
-2.24M
-21.14M
-2.24M
EBIT (TTM)
-10.19M
-23.93M
-10.19M
Net Income (TTM)
-9.70M
-29.93M
-5.66M
Net Income Avl. to Common (TTM)
-9.70M
-29.93M
-5.66M
Earnings Growth (Q YOY)
22.60%
< 10.00%
47.93%
EPS Diluted (TTM)
-1.10
-3.60
-0.64
EPS Diluted Growth (Q YOY)
23.53%
< -10.00%
> 30.00%
Balance Sheet
MRKR
Low
2-Year Historical Range
MRKR
Average
High
Cash and Short-Term Inv. (Q)
9.00M
6.40M
18.12M
Cash Per Share (Q)
1.01
0.73
2.06
Total Current Assets (Q)
10.91M
10.91M
21.96M
Total Assets (Q)
10.91M
10.91M
34.42M
Total Current Liabilities (Q)
3.46M
1.97M
7.78M
Total Debt (Q)
0.00
0.00
7.49M
Total Liabilities (Q)
3.46M
1.97M
14.82M
Total Common Equity (Q)
7.45M
7.45M
19.60M
Total Preferred Equity (Q)
--
--
--
Total Equity (Q)
7.45M
7.45M
19.60M
Current Ratio (Q)
3.153
2.097
7.517
Book Value Per Share (Q)
0.83
0.83
2.33
Cash Flow
MRKR
Low
2-Year Historical Range
MRKR
Average
High
Cash from Operations (TTM)
-8.57M
-26.97M
-8.57M
Cash from Investing (TTM)
0.00
< 0.00
18.78M
Cash from Financing (TTM)
100.50K
100.50K
1.24M
Net Change in Cash (TTM)
-8.47M
< -20.00M
> 0.00
Levered Free Cash Flow (TTM)
-5.25M
-20.17M
-5.25M
TTM - Trailing twelve months. Q - Most recent quarter. YOY - Year over year.
